• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

multiple sclerosis

Outline of human head with female symbol inside
Research

Diabetes drug soothes brain inflammation in female mice with MS

Metformin soothed multiple sclerosis in female, but not male, mice due to its ability to inhibit a gene called Kdm6a, which sits on the X chromosome.
Darren Incorvaia Oct 15, 2025 6:16pm
Sanofi

Sanofi's troubled MS hopeful tolebrutinib hit by FDA delay

Sep 22, 2025 8:00am
human brain abstract art

Thermo Fisher debuts protein panel for neurodegeneration R&D

Sep 16, 2025 12:00pm
pipeline pipes development workers

Contineum shifts cash from MS to lung disease showdown with BMS

Aug 6, 2025 9:51am
Businessman climbing steps to pluck a star from the sky

Roche links BTK drug to low relapse rate across 96-week MS trial

May 30, 2025 5:19am
arrow miss target fail attempt try

Immunic MS asset misses primary goal of midstage trial

Apr 30, 2025 3:05pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings